Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 14 pseudogene (RNU7-14P) is a **pseudogene** related to U7 small nuclear RNA (U7 snRNA). U7 snRNA is an essential component of the U7 small nuclear ribonucleoprotein (snRNP), which is required for the processing of histone pre-mRNA 3′ ends[2][1]. However, as a pseudogene, RNU7-14P does not encode a functional RNA molecule and is not expressed, nor does it play an active biological or therapeutic role[3][7]. Pseudogenes like RNU7-14P are transcriptionally inactive remnants of genes and are not considered viable drug targets or functional biomarkers in clinical practice. Thus, this entry is *not considered a molecular target* and is included in gene databases primarily for genome annotation purposes[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 14 pseudogene (RNU7-14P).